Mark Nespeca - Publications

Affiliations: 
Neurosciences University of California, San Diego, La Jolla, CA 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Cassater D, Bustamante M, Sach-Peltason L, Rotenberg A, Nespeca M, Tan WH, Bird LM, Hipp JF. Clinical Characterization of Epilepsy in Children With Angelman Syndrome. Pediatric Neurology. 124: 42-50. PMID 34536900 DOI: 10.1016/j.pediatrneurol.2021.08.007  0.315
2020 Macdonald-Laurs E, Sharpe C, Nespeca M, Rismanchi N, Gold JJ, Kuperman R, Wang S, Lee NMD, Michelson DJ, Haas R, Reed P, Davis SL. Does the first hour of continuous electroencephalography predict neonatal seizures? Archives of Disease in Childhood. Fetal and Neonatal Edition. PMID 32928896 DOI: 10.1136/Archdischild-2020-318985  0.502
2020 Sharpe C, Reiner GE, Davis SL, Nespeca M, Gold JJ, Rasmussen M, Kuperman R, Harbert MJ, Michelson D, Joe P, Wang S, Rismanchi N, Le NM, Mower A, Kim J, et al. Levetiracetam Versus Phenobarbital for Neonatal Seizures: A Randomized Controlled Trial. Pediatrics. PMID 32385134 DOI: 10.1542/Peds.2019-3182  0.515
2018 Sharpe C, Davis SL, Reiner GE, Lee LI, Gold JJ, Nespeca M, Wang SG, Joe P, Kuperman R, Gardner M, Honold J, Lane B, Knodel E, Rowe D, Battin MR, et al. Assessing the Feasibility of Providing a Real-Time Response to Seizures Detected With Continuous Long-Term Neonatal Electroencephalography Monitoring. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. PMID 30289769 DOI: 10.1097/Wnp.0000000000000525  0.424
2018 Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Currents. 18: 269-278. PMID 30254528 DOI: 10.5698/1535-7597.18.4.269  0.527
2018 Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Currents. 18: 260-268. PMID 30254527 DOI: 10.5698/1535-7597.18.4.260  0.558
2018 Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. PMID 29898974 DOI: 10.1212/WNL.0000000000005756  0.402
2018 Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. PMID 29898971 DOI: 10.1212/Wnl.0000000000005755  0.486
2018 Johannesen KM, Gardella E, Linnankivi T, Courage C, de Saint Martin A, Lehesjoki AE, Mignot C, Afenjar A, Lesca G, Abi-Warde MT, Chelly J, Piton A, Merritt JL, Rodan LH, Tan WH, ... ... Nespeca M, et al. Defining the phenotypic spectrum of SLC6A1 mutations. Epilepsia. PMID 29315614 DOI: 10.1111/Epi.13986  0.301
2015 Rismanchi N, Gold JJ, Sattar S, Glaser CA, Sheriff H, Proudfoot J, Mower A, Crawford JR, Nespeca M, Wang SG. Epilepsy After Resolution of Presumed Childhood Encephalitis. Pediatric Neurology. 53: 65-72. PMID 26092415 DOI: 10.1016/J.Pediatrneurol.2015.03.016  0.484
2014 Gold JJ, Crawford JR, Glaser C, Sheriff H, Wang S, Nespeca M. The role of continuous electroencephalography in childhood encephalitis. Pediatric Neurology. 50: 318-23. PMID 24507696 DOI: 10.1016/J.Pediatrneurol.2013.12.014  0.517
2011 Zimbric MR, Sharpe CM, Albright KC, Nespeca MP. Three-channel electroencephalogram montage in neonatal seizure detection and quantification. Pediatric Neurology. 44: 31-4. PMID 21147384 DOI: 10.1016/j.pediatrneurol.2010.08.014  0.357
2009 Thibert RL, Conant KD, Braun EK, Bruno P, Said RR, Nespeca MP, Thiele EA. Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options. Epilepsia. 50: 2369-76. PMID 19453717 DOI: 10.1111/J.1528-1167.2009.02108.X  0.522
2007 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Continuum Lifelong Learning in Neurology. 13: 212-224. DOI: 10.1212/01.CON.0000284530.12778.9b  0.392
2007 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Appendix C: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society Continuum Lifelong Learning in Neurology. 13: 203-211. DOI: 10.1212/01.CON.0000284529.35649.1d  0.395
2004 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 62: 1261-73. PMID 15111660 DOI: 10.1212/01.Wnl.0000123695.22623.32  0.545
2004 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 62: 1252-60. PMID 15111659 DOI: 10.1212/01.WNL.0000123693.82339.FC  0.517
2004 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 45: 410-23. PMID 15101822 DOI: 10.1111/j.0013-9580.2004.06304.x  0.523
2004 French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 45: 401-9. PMID 15101821 DOI: 10.1111/J.0013-9580.2004.06204.X  0.546
2004 French J, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, et al. Erratum: Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy. Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society (Epilepsia (2004) 45 (410-423)) Epilepsia. 45. DOI: 10.1111/J.0013-9580.2004.20041020.X  0.476
1996 Nespeca M. Your Child and Epilepsy: A Guide to Living Well Journal of Clinical Neurophysiology. 13: 357. DOI: 10.1097/00004691-199607000-00049  0.451
Show low-probability matches.